Jesse M. van den Berg, MD (he/him/his)

PhD student
PHARMO Institute for Drug Outcomes Research, Netherlands

Jesse van den Berg is a medical doctor and researcher at the PHARMO Institute with a focus on studies using General Practitioner data. He obtained his MSc in Medicine from VU University Amsterdam in 2020 and expects to obtain his MSc in Epidemiology from VU University Amsterdam in 2024. He is currently pursuing a PhD in COVID-19 and diabetes at the Department of General Practice at Amsterdam UMC, combined with a residency to become a general practitioner, in addition to his research work at the PHARMO Institute.

Poster(s):

• (351) Rates of SARS-CoV-2 Breakthrough Infection or Severe COVID-19 and Associated Risk Factors After Primary and Booster Vaccination Against COVID-19 in the Netherlands
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (359) Safety of the Janssen COVID-19 vaccine (JCOVDEN) using VAC4EU European Healthcare Data Sources: Methods and Results of the Second Study Feasibility Assessment
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST